160 related articles for article (PubMed ID: 21745014)
1. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.
Haug U; Knudsen AB; Brenner H; Kuntz KM
Expert Rev Mol Diagn; 2011 Jul; 11(6):605-16. PubMed ID: 21745014
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms.
Castro I; Estevez P; Cubiella J; Hernandez V; González-Mao C; Rivera C; Iglesias F; Cid L; Soto S; de-Castro L; Vega P; Hermo JA; Macenlle R; Martínez A; Cid E; Gil I; Larzabal M; Bujanda L; Castells A;
Dig Dis Sci; 2015 May; 60(5):1424-32. PubMed ID: 25407805
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia.
Haug U; Kuntz KM; Knudsen AB; Hundt S; Brenner H
Br J Cancer; 2011 May; 104(11):1779-85. PubMed ID: 21559011
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
[TBL] [Abstract][Full Text] [Related]
5. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
8. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
9. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
10. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
Nagasaka T; Yamaguchi Y
Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.
Collins JF; Lieberman DA; Durbin TE; Weiss DG;
Ann Intern Med; 2005 Jan; 142(2):81-5. PubMed ID: 15657155
[TBL] [Abstract][Full Text] [Related]
17. Fecal occult blood test in colorectal cancer screening.
Li JN; Yuan SY
J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325
[TBL] [Abstract][Full Text] [Related]
18. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.
Bechtold ML; Ashraf I; Nguyen DL
South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809
[TBL] [Abstract][Full Text] [Related]
19. The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9.
Tobi M; Antaki F; Rambus MA; Yang YX; Kaplan D; Rodriguez R; Maliakkal B; Majumdar A; Demian E; Tobi YY; Sochacki P; Ehrinpreis M; Lawson MG; McVicker B
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139086
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
